Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 95

1.

Challenging Knosp high-grade pituitary adenomas.

Micko A, Oberndorfer J, Weninger WJ, Vila G, Höftberger R, Wolfsberger S, Knosp E.

J Neurosurg. 2019 May 31:1-8. doi: 10.3171/2019.3.JNS19367. [Epub ahead of print]

PMID:
31151112
2.

MAPK pathway and B cells overactivation in multiple sclerosis revealed by phosphoproteomics and genomic analysis.

Kotelnikova E, Kiani NA, Messinis D, Pertsovskaya I, Pliaka V, Bernardo-Faura M, Rinas M, Vila G, Zubizarreta I, Pulido-Valdeolivas I, Sakellaropoulos T, Faigle W, Silberberg G, Masso M, Stridh P, Behrens J, Olsson T, Martin R, Paul F, Alexopoulos LG, Saez-Rodriguez J, Tegner J, Villoslada P.

Proc Natl Acad Sci U S A. 2019 May 7;116(19):9671-9676. doi: 10.1073/pnas.1818347116. Epub 2019 Apr 19.

PMID:
31004050
3.

[Other specific types of diabetes and exocrine pancreatic insufficiency (Update 2019)].

Kaser S, Winhofer-Stöckl Y, Kazemi-Shirazi L, Hofer SE, Brath H, Sourij H, Vila G, Abrahamian H, Riedl M, Weitgasser R, Resl M, Clodi M, Luger A.

Wien Klin Wochenschr. 2019 May;131(Suppl 1):16-26. doi: 10.1007/s00508-019-1454-0. German.

PMID:
30980164
4.

Immune tolerance in multiple sclerosis and neuromyelitis optica with peptide-loaded tolerogenic dendritic cells in a phase 1b trial.

Zubizarreta I, Flórez-Grau G, Vila G, Cabezón R, España C, Andorra M, Saiz A, Llufriu S, Sepulveda M, Sola-Valls N, Martinez-Lapiscina EH, Pulido-Valdeolivas I, Casanova B, Martinez Gines M, Tellez N, Oreja-Guevara C, Español M, Trias E, Cid J, Juan M, Lozano M, Blanco Y, Steinman L, Benitez-Ribas D, Villoslada P.

Proc Natl Acad Sci U S A. 2019 Apr 23;116(17):8463-8470. doi: 10.1073/pnas.1820039116. Epub 2019 Apr 8.

5.

Multiple Pituitary Apoplexy-Cavernous Sinus Invasion as Major Risk Factor for Recurrent Hemorrhage.

Hosmann A, Micko A, Frischer JM, Roetzer T, Vila G, Wolfsberger S, Knosp E.

World Neurosurg. 2019 Mar 7. pii: S1878-8750(19)30561-3. doi: 10.1016/j.wneu.2019.02.138. [Epub ahead of print]

PMID:
30851467
6.

Axonal and Myelin Neuroprotection by the Peptoid BN201 in Brain Inflammation.

Villoslada P, Vila G, Colafrancesco V, Moreno B, Fernandez-Diez B, Vazquez R, Pertsovskaya I, Zubizarreta I, Pulido-Valdeolivas I, Messeguer J, Vendrell-Navarro G, Frade JM, López-Sánchez N, Teixido M, Giralt E, Masso M, Dugas JC, Leonoudakis D, Lariosa-Willingham KD, Steinman L, Messeguer A.

Neurotherapeutics. 2019 Feb 27. doi: 10.1007/s13311-019-00717-4. [Epub ahead of print]

PMID:
30815844
7.

GDF15 reflects beta cell function in obese patients independently of the grade of impairment of glucose metabolism.

Schernthaner-Reiter MH, Itariu BK, Krebs M, Promintzer-Schifferl M, Stulnig TM, Tura A, Anderwald CH, Clodi M, Ludvik B, Pacini G, Luger A, Vila G.

Nutr Metab Cardiovasc Dis. 2019 Apr;29(4):334-342. doi: 10.1016/j.numecd.2018.12.008. Epub 2019 Jan 3.

PMID:
30718144
8.

Correction to: Factors predicting long-term comorbidities in patients with Cushing's syndrome in remission.

Schernthaner-Reiter MH, Siess C, Gessl A, Scheuba C, Wolfsberger S, Riss P, Knosp E, Luger A, Vila G.

Endocrine. 2019 Apr;64(1):202. doi: 10.1007/s12020-019-01839-7.

PMID:
30680542
9.

Decreased beta-cell function in breastfeeding obese and non-obese women: A prospective observational study.

Harreiter J, Vila G, Leitner K, Wattar L, Leutner M, Worda C, Bancher-Todesca D, Kautzky-Willer A.

Clin Nutr. 2018 Dec 13. pii: S0261-5614(18)32574-3. doi: 10.1016/j.clnu.2018.11.035. [Epub ahead of print]

PMID:
30583966
10.

Factors predicting long-term comorbidities in patients with Cushing's syndrome in remission.

Schernthaner-Reiter MH, Siess C, Gessl A, Scheuba C, Wolfsberger S, Riss P, Knosp E, Luger A, Vila G.

Endocrine. 2019 Apr;64(1):157-168. doi: 10.1007/s12020-018-1819-6. Epub 2018 Nov 22. Erratum in: Endocrine. 2019 Jan 24;:.

11.

A Multi-feature Fuzzy Index to Assess Stress Level from Bio-signals.

Charbonnier S, Vila G, Godin C, Labyt E, Sakri O, Campagne A.

Conf Proc IEEE Eng Med Biol Soc. 2018 Jul;2018:1086-1089. doi: 10.1109/EMBC.2018.8512499.

PMID:
30440579
12.

Vitamin D and critical illness: what endocrinology can learn from intensive care and vice versa.

Amrein K, Papinutti A, Mathew E, Vila G, Parekh D.

Endocr Connect. 2018 Dec 1;7(12):R304-R315. doi: 10.1530/EC-18-0184. Review.

13.

Endoscopic Transsphenoidal Surgery of Microprolactinomas: A Reappraisal of Cure Rate Based on Radiological Criteria.

Micko A, Vila G, Höftberger R, Knosp E, Wolfsberger S.

Neurosurgery. 2018 Aug 29. doi: 10.1093/neuros/nyy385. [Epub ahead of print]

PMID:
30169711
14.

Growth hormone deficiency and pregnancy: any role for substitution?

Vila G, Luger A.

Minerva Endocrinol. 2018 Dec;43(4):451-457. doi: 10.23736/S0391-1977.18.02834-1. Epub 2018 Mar 8. Review.

PMID:
29521487
15.

MGMT and MSH6 immunoexpression for functioning pituitary macroadenomas.

Micko ASG, Wöhrer A, Höftberger R, Vila G, Marosi C, Knosp E, Wolfsberger S.

Pituitary. 2017 Dec;20(6):643-653. doi: 10.1007/s11102-017-0829-3.

16.

B-type natriuretic peptide increases cortisol and catecholamine concentrations in healthy subjects.

Grimm G, Resl M, Heinisch BB, Hülsmann M, Luger A, Clodi M, Vila G.

J Appl Physiol (1985). 2017 May 1;122(5):1249-1254. doi: 10.1152/japplphysiol.00360.2016. Epub 2016 Dec 22.

17.

Growth differentiation factor 15 increases following oral glucose ingestion: effect of meal composition and obesity.

Schernthaner-Reiter MH, Kasses D, Tugendsam C, Riedl M, Peric S, Prager G, Krebs M, Promintzer-Schifferl M, Clodi M, Luger A, Vila G.

Eur J Endocrinol. 2016 Dec;175(6):623-631.

PMID:
27926473
18.

GDF-15 Is Associated with Cancer Incidence in Patients with Type 2 Diabetes.

Pavo N, Wurm R, Neuhold S, Adlbrecht C, Vila G, Strunk G, Clodi M, Resl M, Brath H, Prager R, Luger A, Pacher R, Hülsmann M.

Clin Chem. 2016 Dec;62(12):1612-1620. Epub 2016 Oct 18.

19.

Targeted multiple biomarker approach in predicting cardiovascular events in patients with diabetes.

Resl M, Clodi M, Vila G, Luger A, Neuhold S, Wurm R, Adlbrecht C, Strunk G, Fritzer-Szekeres M, Prager R, Pacher R, Hülsmann M.

Heart. 2016 Dec 15;102(24):1963-1968. doi: 10.1136/heartjnl-2015-308949. Epub 2016 Jul 25.

PMID:
27456261
20.

Cardiovascular safety of metformin and sulfonylureas in patients with different cardiac risk profiles.

Wurm R, Resl M, Neuhold S, Prager R, Brath H, Francesconi C, Vila G, Strunk G, Clodi M, Luger A, Pacher R, Hülsmann M.

Heart. 2016 Oct 1;102(19):1544-51. doi: 10.1136/heartjnl-2015-308711. Epub 2016 May 25.

PMID:
27226327
21.

[Other specific types of diabetes].

Vila G, Gessl AW, Riedl M, Luger A.

Wien Klin Wochenschr. 2016 Apr;128 Suppl 2:S208-11. doi: 10.1007/s00508-016-0997-6. German.

PMID:
27056389
22.

HORMONE SUBSTITUTION AFTER GASTRIC BYPASS SURGERY IN PATIENTS WITH HYPOPITUITARISM SECONDARY TO CRANIOPHARYNGIOMA.

Wolf P, Winhofer Y, Smajis S, Kruschitz R, Schindler K, Gessl A, Riedl M, Vila G, Raber W, Langer F, Prager G, Ludvik B, Luger A, Krebs M.

Endocr Pract. 2016 May;22(5):595-601. doi: 10.4158/EP15947.OR. Epub 2016 Jan 20.

PMID:
26789341
23.

Lactation and appetite-regulating hormones: increased maternal plasma peptide YY concentrations 3-6 months postpartum.

Vila G, Hopfgartner J, Grimm G, Baumgartner-Parzer SM, Kautzky-Willer A, Clodi M, Luger A.

Br J Nutr. 2015 Oct 28;114(8):1203-8. doi: 10.1017/S0007114515002536. Epub 2015 Aug 24.

PMID:
26299586
24.

Pregnancy outcomes in women with growth hormone deficiency.

Vila G, Akerblad AC, Mattsson AF, Riedl M, Webb SM, Hána V, Nielsen EH, Biller BM, Luger A.

Fertil Steril. 2015 Nov;104(5):1210-7.e1. doi: 10.1016/j.fertnstert.2015.07.1132. Epub 2015 Aug 6.

PMID:
26256649
25.

The role of proto-oncogene GLI1 in pituitary adenoma formation and cell survival regulation.

Lampichler K, Ferrer P, Vila G, Lutz MI, Wolf F, Knosp E, Wagner L, Luger A, Baumgartner-Parzer S.

Endocr Relat Cancer. 2015 Oct;22(5):793-803. doi: 10.1530/ERC-15-0109. Epub 2015 Jul 28.

PMID:
26219678
26.

Strong association of serum- and glucocorticoid-regulated kinase 1 with peripheral and adipose tissue inflammation in obesity.

Schernthaner-Reiter MH, Kiefer F, Zeyda M, Stulnig TM, Luger A, Vila G.

Int J Obes (Lond). 2015 Jul;39(7):1143-50. doi: 10.1038/ijo.2015.41. Epub 2015 Mar 26.

PMID:
25809829
27.

Effects of B-type natriuretic peptide on cardiovascular biomarkers in healthy volunteers.

Resl M, Vila G, Grimm G, Heinisch B, Riedl M, Dieplinger B, Mueller T, Luger A, Clodi M.

J Appl Physiol (1985). 2015 Feb 15;118(4):395-9. doi: 10.1152/japplphysiol.00101.2014. Epub 2014 Dec 24.

28.

Association of nutritional risk index with metabolic biomarkers, appetite-regulatory hormones and inflammatory biomarkers and outcome in patients with chronic heart failure.

Gouya G, Voithofer P, Neuhold S, Storka A, Vila G, Pacher R, Wolzt M, Hülsmann M.

Int J Clin Pract. 2014 Nov;68(11):1293-300. doi: 10.1111/ijcp.12513. Epub 2014 Sep 2.

PMID:
25348381
29.

Target site pharmacokinetics of linezolid after single and multiple doses in diabetic patients with soft tissue infection.

Eslam RB, Burian A, Vila G, Sauermann R, Hammer A, Frenzel D, Minichmayr IK, Kloft C, Matzneller P, Oesterreicher Z, Zeitlinger M.

J Clin Pharmacol. 2014 Sep;54(9):1058-62. doi: 10.1002/jcph.296. Epub 2014 May 20.

PMID:
24677034
30.

Estimated glomerular filtration rate and albuminuria: true predictors of cardiovascular events in obese patients with type 2 diabetes?

Resl M, Vila G, Kraxner R, Pacher R, Luger A, Hülsmann M, Neuhold S, Brath H, Prager R, Clodi M.

Wien Klin Wochenschr. 2013 Oct;125(19-20):629-33. doi: 10.1007/s00508-013-0422-3. Epub 2013 Sep 6.

PMID:
24061697
31.

B-type natriuretic peptide modulates ghrelin, hunger, and satiety in healthy men.

Vila G, Grimm G, Resl M, Heinisch B, Einwallner E, Esterbauer H, Dieplinger B, Mueller T, Luger A, Clodi M.

Diabetes. 2012 Oct;61(10):2592-6. Epub 2012 Jun 14.

32.

The impact of type 2 diabetes on circulating adipokines in patients with metabolic syndrome.

Schindler K, Vila G, Hoppichler F, Lechleitner M, Luger A, Anderwald C, Hoefler J, Tomasec G, Kautzky-Willer A, Ludvik B.

Obes Facts. 2012;5(2):270-6. doi: 10.1159/000338729. Epub 2012 Apr 21.

33.

[Flat, depressed and polypoid colorectal lesions: a comparative study using a index of histological advance].

Barreda C C, Monge Z V, Salazar C F, Barriga C E, Salazar M F, Barriga B J, Irriberry U S, Loyola Z J, Machado M A, Piccini L R, Velarde C H, Vila G S.

Rev Gastroenterol Peru. 2012 Jan-Mar;32(1):16-25. Spanish.

PMID:
22476174
34.

B-type natriuretic peptide (BNP) affects the initial response to intravenous glucose: a randomised placebo-controlled cross-over study in healthy men.

Heinisch BB, Vila G, Resl M, Riedl M, Dieplinger B, Mueller T, Luger A, Pacini G, Clodi M.

Diabetologia. 2012 May;55(5):1400-5. doi: 10.1007/s00125-011-2392-1. Epub 2011 Dec 13.

PMID:
22159910
35.

Serum uric acid is related to cardiovascular events and correlates with N-terminal pro-B-type natriuretic peptide and albuminuria in patients with diabetes mellitus.

Resl M, Clodi M, Neuhold S, Kromoser H, Riedl M, Vila G, Prager R, Pacher R, Strunk G, Luger A, Hülsmann M.

Diabet Med. 2012 Jun;29(6):721-5. doi: 10.1111/j.1464-5491.2011.03515.x.

PMID:
22050532
36.

Functional and quality-of-life results of displaced and nondisplaced proximal humeral fractures treated conservatively.

Torrens C, Corrales M, Vilà G, Santana F, Cáceres E.

J Orthop Trauma. 2011 Oct;25(10):581-7. doi: 10.1097/BOT.0b013e318210ed2f.

PMID:
21886006
37.

A comparison of NT-proBNP and albuminuria for predicting cardiac events in patients with diabetes mellitus.

Clodi M, Resl M, Neuhold S, Hülsmann M, Vila G, Elhenicky M, Strunk G, Abrahamian H, Prager R, Luger A, Pacher R.

Eur J Prev Cardiol. 2012 Oct;19(5):944-51. doi: 10.1177/1741826711420015. Epub 2011 Aug 19.

PMID:
21856715
38.

Opposite effects of serum- and glucocorticoid-regulated kinase-1 and glucocorticoids on POMC transcription and ACTH release.

Reiter MH, Vila G, Knosp E, Baumgartner-Parzer SM, Wagner L, Stalla GK, Luger A.

Am J Physiol Endocrinol Metab. 2011 Aug;301(2):E336-41. doi: 10.1152/ajpendo.00155.2011. Epub 2011 May 17.

39.

Total hip replacement with an uncemented Wagner cone stem for patients with congenital hip dysplasia.

Claramunt RT, Marqués F, León A, Vilà G, Mestre C, Verdié LP.

Int Orthop. 2011 Dec;35(12):1767-70. doi: 10.1007/s00264-011-1218-6. Epub 2011 Feb 12.

40.

The relationship between insulin resistance and the cardiovascular biomarker growth differentiation factor-15 in obese patients.

Vila G, Riedl M, Anderwald C, Resl M, Handisurya A, Clodi M, Prager G, Ludvik B, Krebs M, Luger A.

Clin Chem. 2011 Feb;57(2):309-16. doi: 10.1373/clinchem.2010.153726. Epub 2010 Dec 16.

41.

Differential regulation of plasma obestatin and ghrelin by meal intake and the cholinergic system in lean, but not obese individuals.

Maier C, Riedl M, Vila G, Wolzt M, Clodi M, Ludvik B, Luger A.

J Clin Endocrinol Metab. 2010 Oct;95(10):E214-8. doi: 10.1210/jc.2010-0243. Epub 2010 Jul 21.

PMID:
20660037
42.

Strategies for weight regain after sleeve gastrectomy.

Langer FB, Shakeri-Leidenmühler S, Bohdjalian A, Schoppmann S, Zacherl J, Felberbauer FX, Vila G, Prager G.

Surg Laparosc Endosc Percutan Tech. 2010 Jun;20(3):159-61. doi: 10.1097/SLE.0b013e3181e24f3b. Review. No abstract available.

PMID:
20551813
43.

Acute effects of hydrocortisone on the metabolic response to a glucose load: increase in the first-phase insulin secretion.

Vila G, Krebs M, Riedl M, Baumgartner-Parzer SM, Clodi M, Maier C, Pacini G, Luger A.

Eur J Endocrinol. 2010 Aug;163(2):225-31. doi: 10.1530/EJE-10-0282. Epub 2010 May 18.

PMID:
20484150
44.

Changes in osteopontin and in biomarkers of bone turnover during human endotoxemia.

Grimm G, Vila G, Bieglmayer C, Riedl M, Luger A, Clodi M.

Bone. 2010 Aug;47(2):388-91. doi: 10.1016/j.bone.2010.04.602. Epub 2010 Apr 24.

PMID:
20420943
45.

In vivo evaluation of 3-dimensional polycaprolactone scaffolds for cartilage repair in rabbits.

Martinez-Diaz S, Garcia-Giralt N, Lebourg M, Gómez-Tejedor JA, Vila G, Caceres E, Benito P, Pradas MM, Nogues X, Ribelles JL, Monllau JC.

Am J Sports Med. 2010 Mar;38(3):509-19. doi: 10.1177/0363546509352448. Epub 2010 Jan 21.

PMID:
20093424
46.

Systemic administration of oxytocin reduces basal and lipopolysaccharide-induced ghrelin levels in healthy men.

Vila G, Riedl M, Resl M, van der Lely AJ, Hofland LJ, Clodi M, Luger A.

J Endocrinol. 2009 Oct;203(1):175-9. doi: 10.1677/JOE-09-0227. Epub 2009 Jul 8.

PMID:
19587265
47.

Serum vaspin concentrations in relation to insulin sensitivity following RYGB-induced weight loss.

Handisurya A, Riedl M, Vila G, Maier C, Clodi M, Prikoszovich T, Ludvik B, Prager G, Luger A, Kautzky-Willer A.

Obes Surg. 2010 Feb;20(2):198-203. doi: 10.1007/s11695-009-9882-y. Epub 2009 Jun 9.

PMID:
19506980
48.

Plasma MR-proADM correlates to BMI and decreases in relation to leptin after gastric bypass surgery.

Vila G, Riedl M, Maier C, Struck J, Morgenthaler NG, Handisurya A, Prager G, Ludvik B, Clodi M, Luger A.

Obesity (Silver Spring). 2009 Jun;17(6):1184-8. doi: 10.1038/oby.2009.22. Epub 2009 Feb 26.

49.

Plasma NT-proBNP increases in response to LPS administration in healthy men.

Vila G, Resl M, Stelzeneder D, Struck J, Maier C, Riedl M, Hülsmann M, Pacher R, Luger A, Clodi M.

J Appl Physiol (1985). 2008 Dec;105(6):1741-5. doi: 10.1152/japplphysiol.90442.2008. Epub 2008 Oct 9.

50.

Oxytocin alleviates the neuroendocrine and cytokine response to bacterial endotoxin in healthy men.

Clodi M, Vila G, Geyeregger R, Riedl M, Stulnig TM, Struck J, Luger TA, Luger A.

Am J Physiol Endocrinol Metab. 2008 Sep;295(3):E686-91. doi: 10.1152/ajpendo.90263.2008. Epub 2008 Jul 1.

Supplemental Content

Support Center